Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer

Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer

Real-world data on the use and outcomes of crizotinib in ROS1-rearranged non-small-cell lung cancer (NSCLC) are limited. This study aims to analyze the real-world efficacy of crizotinib in South Korea and explore the utilization of liquid biopsies that implement next-generation sequencing (NGS) usin...

Full description

Bibliographic Details
Main Authors: Hyeon Hwa Kim, Jae Cheol Lee, In-Jae Oh, Eun Young Kim, Seong Hoon Yoon, Shin Yup Lee, Min Ki Lee, Jeong Eun Lee, Chan Kwon Park, Kye Young Lee, Sung Yong Lee, Seung Joon Kim, Jun Hyeok Lim, Chang-min Choi
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
ROS1
non-small-cell lung cancer
crizotinib
real-world efficacy
Online Access:https://www.mdpi.com/2072-6694/16/3/528

Internet

https://www.mdpi.com/2072-6694/16/3/528

Similar Items